American Well Corp Files 2024 10-K
Ticker: AMWL · Form: 10-K · Filed: 2025-02-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, healthcare-technology
TL;DR
AMWL filed its 2024 10-K. Full financials and biz details inside.
AI Summary
American Well Corp filed its 2024 10-K on February 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Boston, MA, operates in the business services sector. Key financial details and operational performance for the year are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of American Well Corp's financial health, operational strategies, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — 10-K filings inherently carry medium risk due to the detailed financial and operational information that can impact stock valuation.
Key Numbers
- 000000000 — IRS Number (Company's IRS identification number)
- 001-39515 — SEC File Number (Company's SEC file number)
Key Players & Entities
- American Well Corp (company) — Filer of the 10-K
- 0000950170-25-019024 (filing_id) — Accession Number for the filing
- 20241231 (date) — Fiscal year end date
- 20250212 (date) — Filing date
- Boston, MA (location) — Company headquarters and mailing address
FAQ
What was American Well Corp's total revenue for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is the primary business segment of American Well Corp?
American Well Corp is classified under SERVICES-BUSINESS SERVICES, NEC [7389].
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 12, 2025.
Where is American Well Corp headquartered?
American Well Corp is headquartered in Boston, MA, with its business and mailing addresses listed at 75 State Street, 26th Floor.
What is the fiscal year end for American Well Corp?
The fiscal year end for American Well Corp is December 31.
From the Filing
0000950170-25-019024.txt : 20250212 0000950170-25-019024.hdr.sgml : 20250212 20250212172811 ACCESSION NUMBER: 0000950170-25-019024 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 105 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250212 DATE AS OF CHANGE: 20250212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Well Corp CENTRAL INDEX KEY: 0001393584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39515 FILM NUMBER: 25616200 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 BUSINESS PHONE: 617-205-3500 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 10-K 1 amwl-20241231.htm 10-K 10-K false 0001393584 FY 0.1 0.05 0.05 3 three years http://fasb.org/srt/2024#ChiefExecutiveOfficerMember http://fasb.org/us-gaap/2024#ProfitLoss http://fasb.org/us-gaap/2024#CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization http://fasb.org/us-gaap/2024#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2024#SellingAndMarketingExpense http://fasb.org/us-gaap/2024#CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2024#SellingAndMarketingExpense http://fasb.org/us-gaap/2024#GeneralAndAdministrativeExpense 0001393584 us-gaap:CommonClassCMember 2025-01-31 0001393584 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0001393584 amwl:CcawJvLlcMember 2024-12-31 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001393584 amwl:NtnMemberMember us-gaap:NoncontrollingInterestMember 2024-12-31 0001393584 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-12-31 0001393584 amwl:ConversaHealthIncMember 2022-12-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2023-01-01 2023-12-31 0001393584 amwl:ContractFulfillmentCostMember 2023-01-01 2023-12-31 0001393584 us-gaap:ParentMember 2022-12-31 0001393584 us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-12-31 0001393584 amwl:UnvestedRestrictedStockMember 2022-01-01 2022-12-31 0001393584 amwl:ClevelandClinicMember 2022-01-01 2022-12-31 0001393584 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001393584 us-gaap:DevelopedTechnologyRightsMember srt:MaximumMember 2024-12-31 0001393584 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001393584 amwl:PlatformSubscriptionMember 2022-01-01 2022-12-31 0001393584 amwl:ClevelandClinicMember 2023-01-01 2023-12-31 0001393584 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001393584 us-gaap:OfficeEquipmentMember 2024-12-31 0001393584 amwl:NtnMemberMember us-gaap:NoncontrollingInterestMember 2023-12-31 0001393584 us-gaap:DomesticCountryMember 2021-12-31 0001393584 us-gaap:StateAndLocalJurisdictionMember 2024-01-01 2024-12-31 0001393584 amwl:EquityAwardPlanMember us-gaap:CommonStockMember 2024-12-31 0001393584 amwl:OthersMember 2023-01-01 2023-12-31 0001393584 us-gaap:CommonClassBMember 2020-09-30 0001393584 us-gaap:NoncontrollingInterestMember 2021-12-31 0001393584 amwl:OthersMember 2024-01-01 2024-12-31 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2024-12-31 0001393584 us-gaap:CommonClassAMember amwl:SilverCloudBonusEscrowMember 2022-01-01 2022-12-31 0001393584 2024-06-28 2024-06-28 0001393584 us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2023-12-31 0001393584 us-gaap:ParentMember amwl:ConversaHealthIncMember 2022-01-01 2022-12-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001393584 amwl:ConversaHealthIncMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001393584 amwl:NtnMemberMember 2024-01-01 2024-12-31 000139